Weaponising Truly Individualised Therapies
For the first time in over two years, we're delighted to be reuniting the neoantigen community in person for the 5th Neoantigen Summit Europe, dedicated to the robust prediction, identification and validation of neoantigens.
Pioneers in this exclusive industry are convening in Amsterdam this April to network and learn from experts in pharma, biotech and academia. Join us for exclusive discussions around shared and personalised neoantigens and discover the full potential of neoantigens in creating truly individualised cancer therapeutics.
From understanding the latest clinical insights to defining and characterising the best epitopes, reviewing vaccines post-COVID to exploring emerging investment in foreign tumour antigens, our 3-day agenda is packed with dedicated content to help you increase precision of high quality neoantigen target identification.
Find out more: https://ter.li/ibzkf4
Time: 08:50 - 16:30